Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Shreeram Aradhye
Age : 58
Country of residence : Unknown
Linked companies : Novartis AG - Dicerna Pharmaceuticals, Inc.

Summary 
Presently, Shreeram Aradhye holds the position of Chief Medical Officer at Novartis AG and Chief Medical Officer & Executive Vice President at Dicerna Pharmaceuticals, Inc. Dr. Aradhye is also on the board of Valo Health LLC.

In his past career Dr. Aradhye was Independent Director at Axcella Health, Inc., Chief Medical Officer at Novartis Pharmaceuticals Corp. and Assistant Professor at the University of Pennsylvania.

Dr. Aradhye received an undergraduate degree from All India Institute of Medical Sciences.




Current positions of Shreeram Aradhye 
Holdings of Shreeram Aradhye 
Shreeram Aradhye : Personal Network 
Most Read News 
11/20Buffett's Berkshire boosts stakes in Japan's five biggest trading houses
RE
11/17Brazil's Buffett-backed StoneCo nearly doubles profits on more users, bigger prices
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
11/18Gates Foundation pledges $7 billion for Africa as Ukraine war diverts donor cash
RE
11/17After Elon Musk's ultimatum, Twitter employees start exiting
RE
11/14Buffett-backed Nubank's revenue surges on robust customer growth
RE
11/18Musk's pay trial asks if Tesla's growth justifies $56 billion compensation
RE
11/16Twitter's ex-CEO Jack Dorsey says will not retake role
RE
11/22'Boomerang CEOs' don't always work out; Disney hopes this one bucks trend
RE
11/17Zuckerberg says WhatsApp business chat will drive sales sooner than metaverse
RE
More news


© 2022 People and Ownership :   
Shreeram Aradhye : Connections 


Latest news about Shreeram Aradhye 
09/22Transcript : Novartis AG - Special Call
CI
05/25Axcella Health Inc. Announces Management Changes
CI
04/04Transcript : Novartis AG - Special Call
CI
04/04Novartis Discloses New Organizational Structure, Expects to Save $1B by 2024
MT
04/04Novartis to save at least $1 billion by 2024 thanks to simplified structure
RE
04/04Novartis Names New Chief Commercial, Chief Medical Officers
MT
04/04Novartis AG Announces Executive Changes
CI
More news